市场调查报告书
商品编码
1535238
ERCP及PTC设备市场:各市场区隔规模,占有率,法律规章,偿付,手术,2033年为止的预测ERCP and PTC Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
内视镜逆行性胰胆管摄影 (ERCP) 是一种针对肝臟和胰臟引流管(包括胆管、胆囊和胰管)的内视镜和放射学联合手术。当胆管严重狭窄且难以透过内视镜观察时,或当先前的手术使内视镜进入变得困难时,经皮肝穿刺胆管造影(PTC)对于进入胆管非常有用。
ERCP 和 PTC 通常用于治疗阻塞性黄疸和控制胆漏(无论是良性还是恶性)。它也用于预防胰臟炎以及排出胆囊和胰液。这些装置主要透过两种方式放置:内视镜逆行性胰胆管摄影(ERCP)和经皮肝穿刺胆管摄影(PTC)。
本报告提供全球ERCP及PTC设备市场相关资料详细考察,提供市场上竞争情形,SWOT分析,到2033年为止的市场预测,地区,各国的趋势等资讯。
ERCP and PTC Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative and qualitative market trends within General Surgery Devices therapeutic area.
Endoscopic Retrograde Cholangiopancreatography (ERCP) is a combined endoscopic and radiologic procedure for the ducts draining the liver and pancreas which includes bile ducts, gallbladder, and pancreatic ducts. Percutaneous Transhepatic Cholangiography (PTC) is useful in accessing the biliary tree when a high-grade stricture precludes endoscopic visualization or when prior surgery makes endoscopic access difficult.
ERCP and PTC devices are often used in the treatment of obstructive jaundice from either benign or malignant causes and in the management of biliary leaks. These devices are also used for preventing pancreatitis and to drain the gallbladder and pancreatic fluids. These devices are placed through two major procedures: Endoscopic Retrograde Cholangio-Pancreatography (ERCP) and Percutaneous transhepatic cholangiography (PTC).
Each of the covered 39 countries color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed ERCP and PTC Devices and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Boston Scientific Corp, ConMed Corp, Cook Medical Inc, Olympus Corp, Merit Medical Systems Inc, and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -